drugset / Trial / NCT01540591

Intralipid for Repeated Implantation Failure

NCT01540591

Phase 2/3 Completed 200 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Intralipid infusion can improve outcome in women with recurrent Intracytoplasmic sperm injection ( ICSI) failure due to elevated TH1 cytokine response.

Timeline

Start
2012-02
Primary completion
2013-09
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Intralipid Other / unclassified 20 % Intravenous

Indications